Vortioxetine improves cognition in mild cognitive impairment

This study investigated the effects of vortioxetine on cognitive function in adults with mild cognitive impairment (MCI). This single-arm, open-label, phase II study enrolled 111 adults with MCI without depressive symptoms to receive 5–10 mg/day vortioxetine for 6 months. Main outcomes assessed: cog...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Sheng Neng, Tan, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483775/
https://www.ncbi.nlm.nih.gov/pubmed/34282748
http://dx.doi.org/10.1097/YIC.0000000000000376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483775/
https://www.ncbi.nlm.nih.gov/pubmed/34282748
http://dx.doi.org/10.1097/YIC.0000000000000376

Ejemplares similares